MN1


Summary: Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis. [provided by RefSeq, Jul 2008].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
MN1 proto-oncogene, transcriptional regulatorMIM:156100Ensembl:ENSG00000169184HGNC:HGNC:7180PA3089322q12.1

GO terms in MN1


Term TypeEvidence TypeGO Term IDGO Des.
MFNDGO:0003674molecular_function
CCNDGO:0005575cellular_component
BPIEAGO:0001957intramembranous ossification
BPIEAGO:0006351transcription, DNA-templated
BPIEAGO:0006355regulation of transcription, DNA-templated
BPIEAGO:0007275multicellular organism development
BPNDGO:0008150biological_process

Gene expression in normal tissue: MN1

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in MN1


DatabasePathway IDPathway Des.

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD394BX-7951
iGMDRD280CYTOCHALASIN B3
iGMDRD679Bistramide A1
iGMDRD797ISOX DUAL2
iGMDRD61Kinetin riboside6
iGMDRD554CHEMBL14341372
iGMDRD76Simvastatin3
iGMDRD126Tipifarnib4
iGMDRD772BRD47703
iGMDRD599Salermide4
iGMDRD387CHIR-990212
iGMDRD60Quinoclamine4
iGMDRD640CAY106182
iGMDRD64Parbendazole1
iGMDRD356PNU-746541
iGMDRD399Selumetinib3
iGMDRD398Sepantronium3
iGMDRD562Navitoclax5
iGMDRD506Fedratinib3
iGMDRD577BIX012942
iGMDRD888Compound 442
iGMDRD885Compound 1101
iGMDRD318PAC-14
iGMDRD255SB2250022
iGMDRD123Isoevodiamine2
iGMDRD901ELCPK1
iGMDRD341Triacsin c3
iGMDRD237ABT-7514
iGMDRD523Cyanoquinoline, 111
iGMDRD330BRD41322
iGMDRD148Pifithrin-mu3
iGMDRD584VER 1550083
iGMDRD886Compound 1541A2
iGMDRD300Tozasertib3
iGMDRD414MST-3122
iGMDRD871BRD63685
iGMDRD366PI-1032
iGMDRD434BMS-5369246
iGMDRD6AM-5803
iGMDRD289Parthenolide2
iGMDRD77Itraconazole1

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in MN1

​​​​